Form 4 · Filed May 18, 2026, 08:06 PM UTC
INO/INOVIO PHARMACEUTICALS, INC.
Humeau Laurent — Chief Scientific Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 15, 2026 | M | other | 4,771 | — | — | 44,671 |
| May 15, 2026 | F | other | 1,712 | $1 | $2,226 | 42,959 |
| May 15, 2026 | M | other | 4,771 | — | — | 0 |
Source: SEC EDGAR raw filing ↗ · Accession 0001770390-26-000004